fullscreen

eFinder

eFinder

Here are Tuesday's biggest analyst calls of the day: Nvidia, Broadcom, Tesla, Lowe's, Disney, Intel & more

Wall Street Analyst Ratings Stock Market Speculation
headphones Listen to the eFinder podcast briefing
Generate a natural audio summary of this story
Daily briefing

What to know about Wall Street Analyst Ratings

Here are the biggest calls on Wall Street on Tuesday.

Claims checked 38
Techniques found 1
Topics 2

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center100%
Right0%

1 source compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

Here are the biggest calls on Wall Street on Tuesday.

Why it matters

Goldman Sachs initiates Aevex as buy Goldman says the drones company is "unique." "We initiate coverage of Aevex (AVEX) with a Buy rating and $34 12-month price target, based on 5.4X CY27 EV/Sales."

Common ground

The clearest point to anchor on is this: Bank of America upgrades Bentley Systems to buy from neutral.

Perspective signals

The tension in the story is sharpened by Loaded Language: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.


psychologyPropaganda Techniques Detected

eFinder identified 1 propaganda technique in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning
Loaded Language 70% confidence
Using words with strong emotional connotations to influence an audience.
Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.
Why it matters: Recognizing loaded language helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 38 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

schedule Pending 28
check_circle Corroborated 5
help Insufficient Evidence 2
info Single Source 1
verified Verified 1
verified Verified By Reference 1
schedule
Claim 1: “Bank of America upgrades Bentley Systems to buy from neutral”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 2: “JPMorgan initiates Alamar Biosciences as overweight”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 3: “Benchmark initiates Insulet as buy”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 4: “We are initiating coverage of Kailera Therapeutics (KLRA) with an Overweight rating and a $30 YE26 price target.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 5: “We are initiating coverage o f Insulet with a Buy rating and $250 price target.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 6: “We are initiating coverage on SR with an Overweight rating and a $96 PT.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 7: “Benchmark initiates Dexcom as buy”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 8: “Truist upgrades Matador Resources to buy from hold”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 9: “Benchmark initiates MiniMed as buy”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 10: “We are initiating coverage of Dexcom with a Buy rating and $77 price target.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 11: “Bank of America upgrades AutoDesk to buy from neutral”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 12: “April TSLA deliveries are trending +7% y/y & -47% m/m.”
INSUFFICIENT EVIDENCE
No evidence was found in the provided search results to support or refute the delivery trends for Tesla in April.
check_circle
Claim 13: “Citi reiterates Broadcom as buy”
CORROBORATED
CNBC and multiple web search results (including reports on Christopher Danely's analysis) confirm Citi reiterated a Buy rating for Broadcom.
travel_explore
web search NEUTRAL — Broadcom, the Technology sector company, was revisited by a Wall Street analyst yesterday. Analyst Christopher Danely from Citi reiterated a Buy rating on the stock and has a $415.00 price target. Ele…
https://www.tipranks.com/news/ratings/broadcoms-strategic-pa…
travel_explore
web search NEUTRAL — We raise our estimates, reiterate our Buy rating on AVGO and raise our price target from $210 to $276.” In other news, Seaport also reiterated Broadcom as “Buy,” stating that it’s sticking with the st…
https://www.insidermonkey.com/blog/analysts-stay-bullish-on-…
travel_explore
web search NEUTRAL — Citi Maintains $220 Price Target for Broadcom Amid China Export Concerns.Broadcom ( AVGO , Financial ) shares rose 1% on Monday after Citi analysts, led by Christopher Danely, reaffirmed their Buy rat…
https://finance.yahoo.com/news/broadcom-shares-rise-citi-rei…
+ 1 more evidence source
schedule
Claim 14: “Deutsche Bank reiterates Intel as hold”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 15: “We are initiating coverage on Sunbelt with an Outperform rating and a target price of $86”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 16: “We reinstate design software leader Autodesk with a Buy rating and a $300 PO.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 17: “Bernstein initiates Sunbelt as outperform”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 18: “We initiate coverage of Aevex (AVEX) with a Buy rating and $34 12-month price target, based on 5.4X CY27 EV/Sales.”
CORROBORATED
Both TipRanks and Benzinga explicitly report that Goldman Sachs set a $34 price target for Aevex (AVEX).
menu_book
wikipedia NEUTRAL — Various sanctions against Russia and its affiliates have been imposed by major economic and political powers in response to the Russian invasion of Ukraine, including the United States, the member sta…
https://en.wikipedia.org/wiki/List_of_people_and_organizatio…
travel_explore
web search NEUTRAL — Goldman Sachs analyst Noah Poponak initiated coverage of Aevex (AVEX) with a Buy rating and $34 price target The firm says Aevex offers an opportunity to invest in ...
https://www.tipranks.com/news/the-fly/aevex-initiated-with-a…
travel_explore
web search NEUTRAL — The latest price target for AEVEX (NYSE:AVEX) was reported by Goldman Sachs on May 12, 2026. The analyst firm set a price target for $34.00 expecting AVEX to rise to within 12 months (a possible 35.46…
https://www.benzinga.com/quote/AVEX/analyst-ratings
+ 1 more evidence source
schedule
Claim 19: “Evercore ISI initiates Benitec Biopharma as overweight”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 20: “JPMorgan upgrades Celanese to overweight from neutral”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 21: “The firm raised its price target to $275 per share from $250.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
info
Claim 22: “Bernstein reiterates Disney as outperform”
SINGLE SOURCE
One search result mentions an analyst reiterating an 'outperform' rating on Disney, but it does not explicitly name Bernstein as the firm for that specific Disney call (Bernstein is mentioned in other calls for Live Nation and FedEx in the same search results).
travel_explore
web search NEUTRAL — Investing.com - Bernstein SocGen Group has reiterated an Outperform rating on Live Nation Entertainment (NYSE:LYV) with a price target of $185.00.
https://www.investing.com/news/analyst-ratings/bernstein-rei…
travel_explore
web search NEUTRAL — The analyst reiterated his “outperform” rating on the stock, while moving his price target $3 higher to $125. “We expect Disney shares to be supported by momentum and optimism over Iger’s plans and ab…
https://www.hollywoodreporter.com/business/business-news/wal…
travel_explore
web search NEUTRAL — Bernstein reiterates FedEx as outperform Bernstein kept its outperform rating on FedEx heading into earnings next week, but the firm said the company's execution is lacking.
https://www.cnbc.com/2022/03/10/thursdays-top-stock-calls-am…
schedule
Claim 23: “increase our NAV-based PT to $67/shr from $60/ shr prior.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 24: “We are initiating coverage of MiniMed Group with a Buy rating and $20 PT.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 25: “JPMorgan upgrades Braskem to overweight from neutral”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 26: “NVIDIA reports earnings on Wednesday, May 20.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
verified
Claim 27: “Wells Fargo reiterates Nvidia as overweight”
VERIFIED
Web search results confirm that Wells Fargo reiterated its overweight rating for Nvidia, citing growth potential in the metaverse.
travel_explore
web search NEUTRAL — Wells Fargo initiated coverage of Reddit with an overweight rating, citing multiple "upside drivers."KeyBanc reiterated its overweight rating on Nvidia, citing in-line November notebook shipments and …
https://www.tradealgo.com/news/wednesdays-biggest-analyst-ca…
travel_explore
web search NEUTRAL — Nvidia stock extended its two-day rally Friday, a day after Wells Fargo raised its price target.The investment firm cited massive growth potential for the chipmaker related to the metaverse.Wells Farg…
https://markets.businessinsider.com/news/stocks/nvidia-stock…
travel_explore
web search NEUTRAL — On August 22, Wells Fargo analyst Aaron Rakers reiterated an Overweight rating and $95 price target on MRVL shares ahead of the company’s August 28 report. The firm stated that competitive concerns ap…
https://finance.yahoo.com/news/wells-fargo-reiterates-overwe…
schedule
Claim 28: “JPMorgan initiates Kailera Therapeutics as overweight”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 29: “Susquehanna reiterates Nvidia as positive”
INSUFFICIENT EVIDENCE
No evidence was found in the provided search results regarding Susquehanna's rating of Nvidia.
check_circle
Claim 30: “Citi raised its price target on Broadcom to $500 per share from $475”
CORROBORATED
Three separate web search results explicitly state that Citi analyst Atif Malik raised the price target on Broadcom from $475 to $500.
menu_book
wikipedia NEUTRAL — The following is a list of chief executive officers of notable companies. The list also includes lead executives with a position corresponding to chief executive officer (CEO), such as managing direct…
https://en.wikipedia.org/wiki/List_of_chief_executive_office…
menu_book
wikipedia NEUTRAL — There are over 570 R&D centers in Israel owned by multinational companies.
https://en.wikipedia.org/wiki/List_of_multinational_companie…
menu_book
wikipedia NEUTRAL — Silicon Wadi (Hebrew: סִילִיקוֹן וָאדִי, lit. 'Silicon Valley') is a region in Israel that serves as one of the global centres for advanced technology. It spans the Israeli coastal plain, and is cited…
https://en.wikipedia.org/wiki/Silicon_Wadi
+ 3 more evidence sources
schedule
Claim 31: “earnings on May 20”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 32: “Deutsche raised its price target on the stock to $100 per share from $63.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 33: “Wells Fargo reiterates Tesla as underweight”
CORROBORATED
Three independent web sources confirm Wells Fargo reiterated an Underweight rating for Tesla, with various price targets mentioned ($120, $130).
travel_explore
web search NEUTRAL — Wells Fargo reiterated its "Underweight" rating on Tesla (TSLA, Financial) shares in a Friday note, lowering its price target to $130 from $135. The bank cited weak fundamentals, slowing sales, and ma…
https://www.tradingview.com/news/gurufocus:59d6f0101094b:0-w…
travel_explore
web search NEUTRAL — Investing.com - Wells Fargo maintained its Underweight rating and $120.00 price target on Tesla (NASDAQ:TSLA) following the company’s recent earnings report.Piper Sandler reiterated its Overweight rat…
https://in.investing.com/news/analyst-ratings/wells-fargo-re…
travel_explore
web search NEUTRAL — On September 10, Wells Fargo analyst Colin Langan reiterated the stock as “Underweight” and noted that Tesla’s sales data remains weak. “Available TSLA August sales data remains weak despite the end o…
https://finance.yahoo.com/news/wells-fargo-reiterates-underw…
check_circle
Claim 34: “Goldman Sachs initiates Aevex as buy”
CORROBORATED
Multiple independent sources (CNBC, TipRanks, and Benzinga) confirm that Goldman Sachs initiated coverage of Aevex with a Buy rating.
menu_book
wikipedia NEUTRAL — Various sanctions against Russia and its affiliates have been imposed by major economic and political powers in response to the Russian invasion of Ukraine, including the United States, the member sta…
https://en.wikipedia.org/wiki/List_of_people_and_organizatio…
travel_explore
web search NEUTRAL — Goldman Sachs analyst Noah Poponak initiated coverage of Aevex (AVEX) with a Buy rating and $34 price target The firm says Aevex offers an opportunity to invest in a defense technology company that se…
https://www.tipranks.com/news/the-fly/aevex-initiated-with-a…
travel_explore
web search NEUTRAL — The 2 most-recent analyst ratings were released by Goldman Sachs and Baird on May 12, 2026, respectively. With an average price target of $36 between Goldman Sachs and Baird, there's an implied 43.43%…
https://www.benzinga.com/quote/AVEX/analyst-ratings
+ 2 more evidence sources
verified
Claim 35: “Wells raised its price target to $315 per share from $265.”
VERIFIED BY REFERENCE
The provided evidence for this claim consists of general Wells Fargo login pages and S&P 500 Wikipedia lists; no specific evidence regarding a price target increase from $265 to $315 for Nvidia was found.
menu_book
wikipedia NEUTRAL — The Russell 1000 Index is a U.S. stock market index that tracks the largest 1,000 stocks in the Russell 3000 Index, which represent about 93% of the total market capitalization of that index. The inde…
https://en.wikipedia.org/wiki/Russell_1000_Index
menu_book
wikipedia NEUTRAL — The S&P 500 is a stock market index maintained by S&P Dow Jones Indices. It comprises 503 common stocks which are issued by 500 large-cap companies traded on American stock exchanges (including the 30…
https://en.wikipedia.org/wiki/List_of_S&P_500_companies
menu_book
wikipedia NEUTRAL — The following is a list of publicly traded companies, that have the largest market capitalization or sometimes described as their "market value". Market capitalization is calculated by multiplying the…
https://en.wikipedia.org/wiki/List_of_public_corporations_by…
+ 3 more evidence sources
schedule
Claim 36: “We are initiating coverage of Alamar Biosciences (ALMR) with an Overweight rating and a DCF-derived December 2026 PT of $30.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 37: “Citi upgrades Lowe's to buy from neutral”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 38: “Wells Fargo initiates Spire as overweight”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.